Idera Pharma (IDRA) Reports In-Line Q2 Loss
Tweet
Share
E-mailGet Alerts IDRA Hot Sheet
Join SI Premium – FREE
Idera Pharma (NASDAQ: IDRA) reported Q2 EPS of ($0.11), in-line with the analyst estimate of ($0.11).
For earnings history and earnings-related data on Idera Pharma (IDRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Regional Director in US Adjusts List of Top Names
- Constellation Brands (STZ) Tops Q1 EPS by 18c
- Evercore ISI Upgrades XPO (XPO) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
